When we knocked down CHIP, c-FLIPL degradation was inhibited after treatment with 17-AAG, which indicated that CHIP modulated c-FLIPL degradation in the NSCLC cell lines. The gene discussed is STUB1; the disease is non-small cell lung carcinoma.